DouglasRoyMestMD

PubMed

• 11 citations
  Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
  Benjamin Bassichis, Gary Blick, Marcus A. Conant, David Condoluci, Michael I. Echavez, Joseph A. Eviatar, Michael H. Gold, Tiffani Hamilton, C. William Hanke, Gail Hum...> ;Dermatologic Surgery. 2012 Jul 1
• 2 citations
  Review and Evaluation of Treatment Procedures Using Injectable Poly-L-Lactic Acid in the Treatment of Human Immunodeficiency Virus–associated Facial Lipoatrophy
  Douglas Mest, Gail Humble> ;The Journal of Clinical and Aesthetic Dermatology. 2010 Dec 1
• 11 citations
  Duration of Correction for Human Immunodeficiency Virus-Associated Lipoatrophy After Retreatment with Injectable Poly-l-Lactic Acid
  D. R. Mest, G. M. Humble> ;Aesthetic Plastic Surgery. 2009 Jul 1
• 16 citations
  Retreatment with injectable poly-l-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study.
  Douglas Mest, Gail Humble> ;Dermatologic Surgery. 2009 Feb 1
• 58 citations
  Safety and Efficacy of Poly‐l‐lactic Acid Injections in Persons with HIV‐Associated Lipoatrophy: The US Experience
  Douglas Mest, Gail Humble> ;Dermatologic Surgery. 2006 Nov 1
• 34 citations
  Safety of Sculptra: a review of clinical trial data.
  Peter Engelhard, Gail Humble, Douglas Mest> ;Journal of Cosmetic and Laser Therapy. 2005 Dec 1
• 8 citations
  Soft tissue augmentation using silicone: an historical review.
  Gail Humble, Douglas Mest> ;Facial Plastic Surgery. 2004 May 1
• 30 citations
  Soft tissue augmentation using sculptra.
  Gail Humble, Douglas Mest> ;Facial Plastic Surgery. 2004 May 1
• 88 citations
  Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection.
  Douglas Mest, David Wong, Kathleen Shimoda, Maury Mulligan, Samuel E. Wilson> ;Anesthesia and Analgesia. 1994 Apr 1
• Join now to see all